JAC Advance Access published online on May 12, 2004
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkh240
© 2004 by The British Society for Antimicrobial Chemotherapy
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Center for Research in Anti-Infectives and Biotechnology,
Department of Medical Microbiology and Immunology, Creighton University
School of Medicine, 2500 California Plaza, Omaha, NE 68178, USA
* To whom correspondence should be addressed. E-mail: ndhanson{at}creighton.edu.
Objectives: In a previous study with
a Salmonella typhimurium strain containing cloned ampC-ampR from Enterobacter
cloacae, it was suggested that ampC expression
must be kept at low levels by AmpR to maintain normal growth and
virulent phenotype. The purpose of this study was to determine whether
findings obtained with a laboratory model can be extended to a virulent
clinical isolate of S. typhimurium expressing the
plasmid-encoded blaCMY-7. Methods: Disc induction assays were carried
out to investigate inducibility of blaCMY-7.
Primer extension and sequence analyses were carried out to map the
transcriptional start site of blaCMY-7 and
determine the relative expression. Growth and invasion potential
of Salmonella strains were monitored by optical
density, viable counts and cell invasion assays. Results: Sequence analysis confirmed the absence
of ampR upstream of blaCMY-7 therefore
confirming the negative results observed using the disc induction
assay. Primer extension analysis mapped the start site of blaCMY-7 transcription
within an ISEcp1-like element.
The relative expression of blaCMY-7 was Conclusion: These findings indicate that the
biological cost of high-level AmpC production can be compensated
by plasmid-encoded factors and not by regulating ampC expression.
Revised March 15, 2004
Accepted March 16, 2004
Original article
Plasmid-encoded functions compensate for the biological
cost of AmpC overexpression in a clinical isolate of Salmonella
typhimurium
![]()
Abstract
965-fold higher than the expression
of a wild-type Citrobacter freundii chromosomal ampC and
4.1-fold
higher than ampC expression from a derepressed
mutant of C. freundii. Growth and the capacity
to invade mammalian cells were not compromised for either the clinical
isolate or the S. typhimurium transconjugant containing blaCMY-7. However, a Salmonella transformant
containing blaCMY-7 exhibited a compromised
phenotype with respect to growth and invasion of mammalian cells.![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
G. A. Jacoby AmpC {beta}-Lactamases Clin. Microbiol. Rev., January 1, 2009; 22(1): 161 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Marciano, O. Y. Karkouti, and T. Palzkill A Fitness Cost Associated With the Antibiotic Resistance Enzyme SME-1 {beta}-Lactamase Genetics, August 1, 2007; 176(4): 2381 - 2392. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. E. Sidjabat, K. M. Townsend, M. Lorentzen, K. S. Gobius, N. Fegan, J. J.-C. Chin, K. A. Bettelheim, N. D. Hanson, J. C. Bensink, and D. J. Trott Emergence and spread of two distinct clonal groups of multidrug-resistant Escherichia coli in a veterinary teaching hospital in Australia. J. Med. Microbiol., August 1, 2006; 55(Pt 8): 1125 - 1134. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Schmidtke and N. D. Hanson Model System To Evaluate the Effect of ampD Mutations on AmpC-Mediated {beta}-Lactam Resistance. Antimicrob. Agents Chemother., June 1, 2006; 50(6): 2030 - 2037. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. E. Sidjabat, K. M. Townsend, N. D. Hanson, J. M. Bell, H. W. Stokes, K. S. Gobius, S. M. Moss, and D. J. Trott Identification of blaCMY-7 and associated plasmid-mediated resistance genes in multidrug-resistant Escherichia coli isolated from dogs at a veterinary teaching hospital in Australia J. Antimicrob. Chemother., May 1, 2006; 57(5): 840 - 848. [Abstract] [Full Text] [PDF] |
||||




